YOLFTbeta
CHOSA Oncology AB

CHOSA Oncology AB

CHOSA · ST · Healthcare / Biotechnology

0.542SEK+0.06 (+11.29%)

Price History

Full chart

Market Stats

Previous Close0.487
Open0.499
Day Range0.455 – 0.542
52-Week Range0.504 – 1.68
Volume82.91K
Market Cap49.74M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta-0.01
50-Day Avg0.6926
200-Day Avg0.8121

About

Chosa Oncology AB, together with its subsidiaries, engages in developing and commercializing medicines for the treatment of cancer in Sweden and USA. It provides Platin-DRP, a multigene mRNA-based algorithm that predicts a patient's response to platinum-based chemotherapy; and LiPlaCis, a liposomal formulation of cisplatin, enabling delivery of chemotherapy agent directly to tumor sites. The company was formerly known as Chosa ApS. Chosa Oncology AB was incorporated in 2015 and is based in Malmö, Sweden.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Peter Buhl Jensen Adj Professor, M.D., Ph.D.
  • Employees2
  • HeadquartersKungsgatan 6, Malmö, Sweden, 211 49, Sweden
  • Websitehttps://www.chosaoncology.com

Leadership

  • Mr. Peter Buhl Jensen Adj Professor, M.D., Ph.D.Chief Executive Officer · b. 1955
  • Ms. Ulla Hald BuhlCOO & Board Member · b. 1964
  • Mr. Claus Frisenberg PedersenChief Commercial Officer & Board Member · b. 1972
  • Mr. Gerton JonssonChief Financial Officer · b. 1971

Financials

Income Statement

Currency: SEK2022-12-312023-12-312024-12-312025-12-31
Total Revenue0000
Cost of Revenue---4.11M-4.61M
Gross Profit--4.11M4.61M
Operating Expense--9.71M10.84M
Operating Income-1.17M-23.51M-5.60M-6.23M
EBITDA-667.00K-22.47M-4.77M-5.89M
Net Income-1.02M-23.94M-4.77M-5.61M
Interest Expense0514.57K22.62K5.80K

Balance Sheet

Currency: SEK2022-12-312023-12-312024-12-312025-12-31
Total Assets11.90M19.43M21.40M20.25M
Total Liabilities282.00K2.02M2.77M3.71M
Total Equity11.61M17.41M18.63M16.54M
Cash966.00K8.77M6.44M1.79M

Cash Flow

Currency: SEK2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-494.00K1.20M-4.00M-4.02M
Capital Expenditure37.00K04.11M4.61M
Free Cash Flow-531.00K1.20M-8.11M-8.63M
FCF to OCF107.49%100.00%202.88%214.49%

Key Statistics & Ratios

Market Cap49.74M
Enterprise Value46.82M
Trailing P/E0.00
Forward P/E0.00
Price / Sales14.37
Price / Book2.91
EPS-0.01
Book Value0.217
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-6.65M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-37.75%
Return on Assets-24.67%
Shares Outstanding91.44M
Shares Float53.39M
Beta-0.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%